Connect with us

Healthcare

Dr. Fauci says he wore a mask to avoid ‘giving mixed signals’

Published

on

Screen Shot 2021 05 18 at 12.58.58 PM scaled

National Institute of Allergies and Infectious Diseases Director Dr. Fauci appeared on “Good Morning America” Tuesday, to say he only wore a mask after being vaccinated to maintain his image. This comes after the Center for Disease Control and Prevention announced that vaccinated persons are not required to continue wearing a mask.

Anchor George Stephanopoulos asked Fauci how he’s changed his personal mask policy. And the response was something many have thought all along: for theater. He said he had been wearing a mask despite being vaccinated because of his position.

“I didn’t want to look like I was giving mixed signals,” Fauci said. “But being a fully vaccinated person, the chances of my getting infected in an indoor setting is extremely low.”

“That’s why in indoor settings now, I feel comfortable about not wearing a mask,” he admitted.

Just in March, Sen. Rand Paul (R-KY) accused Fauci of such during a hearing. “You parade around in a mask for show,” Paul said to Fauci.

RELATED: Rand Paul: ‘Dr. Fauci needs to put up or shut up’

“You have the vaccine and you’re wearing two masks, isn’t that theater?” Paul asked Fauci

“Here we go again with the theater,” Fauci replied, sounding frustrated. He ended the discussion by reiterating: “Let me just state for the record masks are not theater. Masks are protective.”

But now he’s changed his tune. Paul, for his part, contracted the virus last year. Ever since, he’s refused to get a vaccine, one of three U.S. senators that remain unvaccinated. He also reportedly walks around maskless in the Capitol.

You can follow Jenny Goldsberry on Twitter @jennyjournalism

You may like

Continue Reading

China

FDA will work with China to import cancer drugs due to U.S. shortages

Published

on

FinalFDAshutterstock 1044596995

Earlier this week the United States Food and Drug Administration (FDA) announced it will be working to import chemotherapy drugs from, of all places, China. The drug, called Cisplatin, is to help “ramp up supply amidst rampant drug shortages in the U.S.” reports Foreign Desk News.

Foreign Desk News writes:

Cisplatin comes from drugmaker Qilu Pharmaceutical, which is marketed and produced in China but has not been approved by the FDA. According to a May 24 letter, Qilu will work with the Canadian-based drug company Apotex to import and distribute the medication, which will come in 50-milligram vials with Chinese labels.

“The FDA is responding to yet another generic drug shortage,” said Edmund F. Haislmaier, an expert in healthcare policy and markets at The Heritage Foundation. “The underlying cause of those shortages is that generic drugs have become low-margin commodity products,” he added.

Last week on Twitter, FDA commissioner Dr. Robert Califf said the partnership with Qilu Pharmaceutical is temporary but will provide patients with a potentially life-extending drug.

“The public should rest assured that we will continue all efforts within our authority to help the industry that manufactures and distributes these drugs meet all patient needs for the oncology drugs impacted by shortages,” Califf said.

Foreign Desk News adds:

The latest move by the FDA is sure to spark concern and debate in Congress, as lawmakers in the House and Senate have called on the Biden administration to de-couple the U.S. economy from the Chinese markets, given Beijing’s aggressive push to expand in the South-China Sea and eventually take over the island state of Taiwan. China has also spread illegal and dangerous synthetic opioids and fentanyl drugs across the U.S. southern border, resulting in the devastating deaths of many Americans.

 

You may like

Continue Reading
Advertisement
-->

Trending Now

Advertisement
-->

Trending